Ledipasvir/sofosbuvir and ribavirin for the treatment of ribavirin-refractory persistent hepatitis E virus infection
Persistent Hepatitis E Virus infection (HEV) is a rare but increasingly recognised condition in immunocompromised individuals. Untreated, this infection can rapidly progress to cirrhosis. Ribavirin is recommended as the first line treatment and the majority achieve sustained viral clearance. However...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2023-01-01
|
| Serie: | IDCases |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2214250923000653 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|